RIGA, Latvia — Dr. Kanans Visvanats, Founder of Zoar Limited, has been officially admitted as an Honorary Member of the Latvian Academy of Sciences (LZA). The honor recognizes his contributions to pharmaceutical research, development, and the manufacturing of oncology treatments aimed at improving healthcare accessibility in emerging markets. His work focuses on targeted, extract-based therapeutics and accessible pharmaceutical innovation, supported by 15 patents for anti-cancer and anti-malarial formulations. “I am deeply humbled to receive this milestone recognition from the Latvian Academy of Sciences,” said Dr. Visvanats. This honor validates our ongoing mission to challenge high-cost pharmaceutical models and deliver affordable, high-efficacy healthcare solutions to developing economies.”